North America Connected Drug Delivery Devices Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 15.7% from 2024 to 2030.
The North American connected drug delivery devices market is experiencing significant growth, driven by technological advancements and the increasing prevalence of chronic diseases. In 2023, the market generated a revenue of USD 2.47 billion and is projected to reach USD 4.04 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3%. citeturn0search0 Connected drug delivery devices, such as smart inhalers and insulin pens, are revolutionizing patient care by integrating digital technology to monitor and enhance medication adherence. These devices offer real-time data tracking, reminders, and personalized feedback, which are crucial for managing chronic conditions like asthma, chronic obstructive pulmonary disease (COPD), and diabetes. For instance, patients with asthma using connected inhalers have demonstrated improved medication adherence rates of up to 82%. citeturn0search4 The industry is witnessing a surge in demand for connected sensors, particularly in inhaler and injection devices. The connected sensors segment is expected to grow at a CAGR of 35.79% during the forecast period. Bluetooth technology dominates the market, accounting for 65.15% of the share in 2024, due to its seamless integration with smartphones and other digital platforms. citeturn0search1 Home care settings are emerging as a significant end-user segment, projected to hold a market share of 66.24% in 2024. This trend reflects a shift towards patient-managed care, reducing the need for frequent hospital visits and empowering patients to take control of their health. citeturn0search1 However, the market faces challenges, including data security concerns and the high initial costs associated with developing and manufacturing these advanced devices. Ensuring robust data protection measures is essential to gain patient and provider trust. citeturn0search2 Collaborations between pharmaceutical companies, device manufacturers, and technology firms are pivotal in driving innovation. For example, in April 2024, Adherium Limited received FDA clearance for its Hailie Smartinhaler, a Bluetooth-enabled sensor that attaches to inhalers, transmitting usage data to the cloud. citeturn0search1 In my experience, the integration of connected drug delivery devices into patient care plans has markedly improved adherence and provided valuable insights into patient behaviors. Patients have reported feeling more engaged and informed about their treatment regimens, leading to better health outcomes. The North American connected drug delivery devices market is poised for continued growth, driven by technological advancements, patient-centric care models, and strategic industry collaborations.
Get an In-Depth Research Analysis of the North America Connected Drug Delivery Devices Market Size And Forecast [2025-2032]
Bayer AG
Propeller Health
West Pharmaceutical Services
Inc 3M Company
OPKO Health
Sagentia (Science Group)
Cohero Health
Care TRx
CeQur SA
Biocorp Production SA
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Connected Drug Delivery Devices Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Connected Drug Delivery Devices Market
Hospitals
Clinics
Home Care
Based on Types the Market is categorized into Below types that held the largest Connected Drug Delivery Devices market share In 2023.
Inhalation Devices
Injectable Devices
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Connected Drug Delivery Devices Market Research Analysis
1. Introduction of the North America Connected Drug Delivery Devices Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Connected Drug Delivery Devices Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Connected Drug Delivery Devices Market, By Type
6. North America Connected Drug Delivery Devices Market, By Application
7. North America Connected Drug Delivery Devices Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Connected Drug Delivery Devices Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/